MeVis Medical Solutions AG (M3V.DE)
EUR 25.8
(1.57%)
EUR 25.8
(1.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 28.05 Million EUR | -10.09% |
| 2022 | 31.2 Million EUR | 13.32% |
| 2021 | 27.53 Million EUR | -0.93% |
| 2020 | 27.79 Million EUR | 16.18% |
| 2019 | 23.91 Million EUR | -37.74% |
| 2018 | 38.41 Million EUR | -21.72% |
| 2017 | 49.07 Million EUR | 14.13% |
| 2016 | 43 Million EUR | -5.59% |
| 2015 | 45.54 Million EUR | 19.07% |
| 2014 | 38.25 Million EUR | 11.29% |
| 2013 | 34.37 Million EUR | 11.19% |
| 2012 | 30.91 Million EUR | -5.02% |
| 2011 | 32.54 Million EUR | -16.08% |
| 2010 | 38.78 Million EUR | -23.88% |
| 2009 | 50.95 Million EUR | -14.48% |
| 2008 | 59.58 Million EUR | 67.49% |
| 2007 | 35.57 Million EUR | 290.81% |
| 2006 | 9.1 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 25.13 Million EUR | -10.42% |
| 2024 Q2 | 25.13 Million EUR | 0.0% |
| 2023 Q3 | 28.05 Million EUR | 15.1% |
| 2023 Q4 | 28.05 Million EUR | 0.0% |
| 2023 Q1 | 24.37 Million EUR | -21.88% |
| 2023 Q2 | 24.37 Million EUR | 0.0% |
| 2023 FY | 28.05 Million EUR | -10.09% |
| 2022 FY | 31.2 Million EUR | 13.32% |
| 2022 Q1 | 25.51 Million EUR | -7.34% |
| 2022 Q2 | 25.51 Million EUR | 0.0% |
| 2022 Q3 | 31.2 Million EUR | 22.29% |
| 2022 Q4 | 31.2 Million EUR | 0.0% |
| 2021 Q1 | 24.38 Million EUR | -12.25% |
| 2021 Q2 | 24.38 Million EUR | 0.0% |
| 2021 Q3 | 27.53 Million EUR | 12.91% |
| 2021 Q4 | 27.53 Million EUR | 0.0% |
| 2021 FY | 27.53 Million EUR | -0.93% |
| 2020 Q3 | 27.79 Million EUR | 11.72% |
| 2020 FY | 27.79 Million EUR | 16.18% |
| 2020 Q1 | 24.87 Million EUR | 4.0% |
| 2020 Q2 | 24.87 Million EUR | 0.0% |
| 2020 Q4 | 27.79 Million EUR | 0.0% |
| 2019 FY | 23.91 Million EUR | -37.74% |
| 2019 Q4 | 23.91 Million EUR | -42.7% |
| 2019 Q3 | 41.74 Million EUR | 4.55% |
| 2019 Q2 | 39.93 Million EUR | -2.4% |
| 2019 Q1 | 40.91 Million EUR | 6.48% |
| 2018 Q2 | 41.85 Million EUR | -9.22% |
| 2018 Q1 | 46.1 Million EUR | -6.05% |
| 2018 FY | 38.41 Million EUR | -21.72% |
| 2018 Q3 | 43.9 Million EUR | 4.89% |
| 2018 Q4 | 38.41 Million EUR | -12.49% |
| 2017 FY | 49.07 Million EUR | 14.13% |
| 2017 Q4 | 49.07 Million EUR | 2.98% |
| 2017 Q3 | 47.65 Million EUR | -1.56% |
| 2017 Q2 | 48.41 Million EUR | 2.16% |
| 2017 Q1 | 47.38 Million EUR | 10.19% |
| 2016 Q2 | 45.89 Million EUR | 0.76% |
| 2016 Q4 | 43 Million EUR | 0.92% |
| 2016 FY | 43 Million EUR | -5.59% |
| 2016 Q1 | 45.54 Million EUR | 1.64% |
| 2016 Q3 | 42.61 Million EUR | -7.16% |
| 2015 Q1 | 38.25 Million EUR | 1.57% |
| 2015 Q3 | 42.11 Million EUR | 6.16% |
| 2015 FY | 45.54 Million EUR | 19.07% |
| 2015 Q4 | 44.81 Million EUR | 6.42% |
| 2015 Q2 | 39.67 Million EUR | 3.7% |
| 2014 Q4 | 37.66 Million EUR | 6.47% |
| 2014 FY | 38.25 Million EUR | 11.29% |
| 2014 Q3 | 35.37 Million EUR | 2.73% |
| 2014 Q2 | 34.43 Million EUR | 0.17% |
| 2014 Q1 | 34.37 Million EUR | 1.62% |
| 2013 Q3 | 32.47 Million EUR | 2.49% |
| 2013 Q4 | 33.82 Million EUR | 4.17% |
| 2013 FY | 34.37 Million EUR | 11.19% |
| 2013 Q1 | 30.91 Million EUR | -8.57% |
| 2013 Q2 | 31.68 Million EUR | 2.48% |
| 2012 Q1 | 32.54 Million EUR | -15.7% |
| 2012 Q3 | 33.34 Million EUR | 1.95% |
| 2012 Q4 | 33.81 Million EUR | 1.42% |
| 2012 FY | 30.91 Million EUR | -5.02% |
| 2012 Q2 | 32.7 Million EUR | 0.47% |
| 2011 FY | 32.54 Million EUR | -16.08% |
| 2011 Q2 | 38.82 Million EUR | 0.09% |
| 2011 Q1 | 38.78 Million EUR | -24.42% |
| 2011 Q3 | 37.69 Million EUR | -2.9% |
| 2011 Q4 | 38.61 Million EUR | 2.44% |
| 2010 Q2 | 51.1 Million EUR | 0.28% |
| 2010 FY | 38.78 Million EUR | -23.88% |
| 2010 Q1 | 50.95 Million EUR | 0.0% |
| 2010 Q4 | 51.31 Million EUR | -0.63% |
| 2010 Q3 | 51.63 Million EUR | 1.05% |
| 2009 FY | 50.95 Million EUR | -14.48% |
| 2009 Q3 | 56.14 Million EUR | 0.0% |
| 2008 FY | 59.58 Million EUR | 67.49% |
| 2007 FY | 35.57 Million EUR | 290.81% |
| 2006 FY | 9.1 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| DocCheck AG | 59.1 Million EUR | 52.538% |
| CompuGroup Medical SE & Co. KGaA | 1.89 Billion EUR | 98.523% |
| Nexus AG | 411.71 Million EUR | 93.186% |